146 related articles for article (PubMed ID: 29436103)
1. Genomic hotspots but few recurrent fusion genes in breast cancer.
Fimereli D; Fumagalli D; Brown D; Gacquer D; Rothé F; Salgado R; Larsimont D; Sotiriou C; Detours V
Genes Chromosomes Cancer; 2018 Jul; 57(7):331-338. PubMed ID: 29436103
[TBL] [Abstract][Full Text] [Related]
2. Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer.
Kalyana-Sundaram S; Shankar S; Deroo S; Iyer MK; Palanisamy N; Chinnaiyan AM; Kumar-Sinha C
Neoplasia; 2012 Aug; 14(8):702-8. PubMed ID: 22952423
[TBL] [Abstract][Full Text] [Related]
3. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications.
Veeraraghavan J; Ma J; Hu Y; Wang XS
Breast Cancer Res Treat; 2016 Jul; 158(2):219-32. PubMed ID: 27372070
[TBL] [Abstract][Full Text] [Related]
4. Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.
Hartmaier RJ; Trabucco SE; Priedigkeit N; Chung JH; Parachoniak CA; Vanden Borre P; Morley S; Rosenzweig M; Gay LM; Goldberg ME; Suh J; Ali SM; Ross J; Leyland-Jones B; Young B; Williams C; Park B; Tsai M; Haley B; Peguero J; Callahan RD; Sachelarie I; Cho J; Atkinson JM; Bahreini A; Nagle AM; Puhalla SL; Watters RJ; Erdogan-Yildirim Z; Cao L; Oesterreich S; Mathew A; Lucas PC; Davidson NE; Brufsky AM; Frampton GM; Stephens PJ; Chmielecki J; Lee AV
Ann Oncol; 2018 Apr; 29(4):872-880. PubMed ID: 29360925
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
Natrajan R; Wilkerson PM; Marchiò C; Piscuoglio S; Ng CK; Wai P; Lambros MB; Samartzis EP; Dedes KJ; Frankum J; Bajrami I; Kopec A; Mackay A; A'hern R; Fenwick K; Kozarewa I; Hakas J; Mitsopoulos C; Hardisson D; Lord CJ; Kumar-Sinha C; Ashworth A; Weigelt B; Sapino A; Chinnaiyan AM; Maher CA; Reis-Filho JS
J Pathol; 2014 Apr; 232(5):553-65. PubMed ID: 24395524
[TBL] [Abstract][Full Text] [Related]
6. Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples.
Kim J; Kim S; Ko S; In YH; Moon HG; Ahn SK; Kim MK; Lee M; Hwang JH; Ju YS; Kim JI; Noh DY; Kim S; Park JH; Rhee H; Kim S; Han W
Genes Chromosomes Cancer; 2015 Nov; 54(11):681-91. PubMed ID: 26227178
[TBL] [Abstract][Full Text] [Related]
7. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.
Lee S; Hu Y; Loo SK; Tan Y; Bhargava R; Lewis MT; Wang XS
Proc Natl Acad Sci U S A; 2020 May; 117(18):9912-9921. PubMed ID: 32321829
[TBL] [Abstract][Full Text] [Related]
8. The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
Vitale SR; Ruigrok-Ritstier K; Timmermans AM; Foekens R; Trapman-Jansen AMAC; Beaufort CM; Vigneri P; Sleijfer S; Martens JWM; Sieuwerts AM; Jansen MPHM
BMC Cancer; 2022 Feb; 22(1):165. PubMed ID: 35151276
[TBL] [Abstract][Full Text] [Related]
9. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
[TBL] [Abstract][Full Text] [Related]
10. Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.
Loo SK; Yates ME; Yang S; Oesterreich S; Lee AV; Wang XS
Genes Chromosomes Cancer; 2022 May; 61(5):261-273. PubMed ID: 35106856
[TBL] [Abstract][Full Text] [Related]
11. Identification of fusion genes in breast cancer by paired-end RNA-sequencing.
Edgren H; Murumagi A; Kangaspeska S; Nicorici D; Hongisto V; Kleivi K; Rye IH; Nyberg S; Wolf M; Borresen-Dale AL; Kallioniemi O
Genome Biol; 2011; 12(1):R6. PubMed ID: 21247443
[TBL] [Abstract][Full Text] [Related]
12. Fusion Genes in Breast Cancer.
Kim J; Han W
Adv Exp Med Biol; 2021; 1187():147-157. PubMed ID: 33983577
[TBL] [Abstract][Full Text] [Related]
13. Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer.
Basudan A; Priedigkeit N; Hartmaier RJ; Sokol ES; Bahreini A; Watters RJ; Boisen MM; Bhargava R; Weiss KR; Karsten MM; Denkert C; Blohmer JU; Leone JP; Hamilton RL; Brufsky AM; Elishaev E; Lucas PC; Lee AV; Oesterreich S
Mol Cancer Res; 2019 Feb; 17(2):457-468. PubMed ID: 30355675
[TBL] [Abstract][Full Text] [Related]
14. Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.
Lei JT; Shao J; Zhang J; Iglesia M; Chan DW; Cao J; Anurag M; Singh P; He X; Kosaka Y; Matsunuma R; Crowder R; Hoog J; Phommaly C; Goncalves R; Ramalho S; Peres RMR; Punturi N; Schmidt C; Bartram A; Jou E; Devarakonda V; Holloway KR; Lai WV; Hampton O; Rogers A; Tobias E; Parikh PA; Davies SR; Li S; Ma CX; Suman VJ; Hunt KK; Watson MA; Hoadley KA; Thompson EA; Chen X; Kavuri SM; Creighton CJ; Maher CA; Perou CM; Haricharan S; Ellis MJ
Cell Rep; 2018 Aug; 24(6):1434-1444.e7. PubMed ID: 30089255
[TBL] [Abstract][Full Text] [Related]
15. Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.
Matissek KJ; Onozato ML; Sun S; Zheng Z; Schultz A; Lee J; Patel K; Jerevall PL; Saladi SV; Macleay A; Tavallai M; Badovinac-Crnjevic T; Barrios C; Beşe N; Chan A; Chavarri-Guerra Y; Debiasi M; Demirdögen E; Egeli Ü; Gökgöz S; Gomez H; Liedke P; Tasdelen I; Tolunay S; Werutsky G; St Louis J; Horick N; Finkelstein DM; Le LP; Bardia A; Goss PE; Sgroi DC; Iafrate AJ; Ellisen LW
Cancer Discov; 2018 Mar; 8(3):336-353. PubMed ID: 29242214
[TBL] [Abstract][Full Text] [Related]
16. Chromothripsis in Human Breast Cancer.
Bolkestein M; Wong JKL; Thewes V; Körber V; Hlevnjak M; Elgaafary S; Schulze M; Kommoss FKF; Sinn HP; Anzeneder T; Hirsch S; Devens F; Schröter P; Höfer T; Schneeweiss A; Lichter P; Zapatka M; Ernst A
Cancer Res; 2020 Nov; 80(22):4918-4931. PubMed ID: 32973084
[TBL] [Abstract][Full Text] [Related]
17. RWCFusion: identifying phenotype-specific cancer driver gene fusions based on fusion pair random walk scoring method.
Zhao J; Li X; Yao Q; Li M; Zhang J; Ai B; Liu W; Wang Q; Feng C; Liu Y; Bai X; Song C; Li S; Li E; Xu L; Li C
Oncotarget; 2016 Sep; 7(38):61054-61068. PubMed ID: 27506935
[TBL] [Abstract][Full Text] [Related]
18. INTEGRATE: gene fusion discovery using whole genome and transcriptome data.
Zhang J; White NM; Schmidt HK; Fulton RS; Tomlinson C; Warren WC; Wilson RK; Maher CA
Genome Res; 2016 Jan; 26(1):108-18. PubMed ID: 26556708
[TBL] [Abstract][Full Text] [Related]
19. FuGePrior: A novel gene fusion prioritization algorithm based on accurate fusion structure analysis in cancer RNA-seq samples.
Paciello G; Ficarra E
BMC Bioinformatics; 2017 Jan; 18(1):58. PubMed ID: 28114882
[TBL] [Abstract][Full Text] [Related]
20. Reanalysis of RNA-sequencing data reveals several additional fusion genes with multiple isoforms.
Kangaspeska S; Hultsch S; Edgren H; Nicorici D; Murumägi A; Kallioniemi O
PLoS One; 2012; 7(10):e48745. PubMed ID: 23119097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
